Experimental study on effects of berberine combined with 6-shogaol on intestinal inflammation and flora in mice with ulcerative colitis.
10.19540/j.cnki.cjcmm.20220413.401
- Author:
Hai-Liang WEI
1
;
Jing-Tao LI
2
;
Zhi-Guo CHEN
1
;
Shu-Guang YAN
3
Author Information
1. Department of General Surgery, the Affiliated Hospital of Shannxi University of Chinese Medicine Xianyang 712000, China.
2. Department of Infectious Disease, the Affiliated Hospital of Shannxi University of Chinese Medicine Xianyang 712000, China.
3. College of Basic Medicine, Shannxi University of Chinese Medicine Xianyang 712046, China.
- Publication Type:Journal Article
- Keywords:
6-shogaol;
berberine;
intestinal flora;
intestinal inflammation;
ulcerative colitis
- MeSH:
Animals;
Berberine/therapeutic use*;
Catechols;
Claudin-1/therapeutic use*;
Colitis/metabolism*;
Colitis, Ulcerative/metabolism*;
Colon;
Dextran Sulfate/metabolism*;
Disease Models, Animal;
Drugs, Chinese Herbal/pharmacology*;
Inflammation/metabolism*;
Interleukin-6/metabolism*;
Mice;
Mice, Inbred C57BL;
Mucin-2/pharmacology*;
Tumor Necrosis Factor-alpha/metabolism*
- From:
China Journal of Chinese Materia Medica
2022;47(16):4418-4427
- CountryChina
- Language:Chinese
-
Abstract:
Cold-heat combination is a common method in the treatment of ulcerative colitis, which is represented by classic drug pair, Coptidis Rhizoma and Zingiberis Rhizoma.The present study explored the synergetic effects of berberine and 6-shogaol, the primary components of Coptidis Rhizoma and Zingiberis Rhizoma, respectively, on intestinal inflammation and intestinal flora in mice with ulcerative colitis to reveal the effect and mechanism of cold-heat combination in the treatment of ulcerative colitis.The ulcerative colitis model was induced by dextran sulfate sodium(DSS) in mice.The model mice were administered with berberine(100 mg·kg~(-1)), 6-shogaol(100 mg·kg~(-1)), and berberine(50 mg·kg~(-1)) combined 6-shogaol(50 mg·kg~(-1)) by gavage, once per day.After 20 days of drug administration, mouse serum, colon tissues, and feces were sampled.Hematoxylin-eosin(HE) staining was used to observe histopathological changes in colon tissues.Alcian blue/periodic acid-Schiff(AB/PAS) staining was used to observe the changes in the mucus layer of colon tissues.Enzyme-linked immunosorbent assay(ELISA) was employed to detect the serum content of tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), and interleukin-6(IL-6).Immunohistochemical method was adopted to detect the protein expression of macrophage surface markers F4/80, mucin-2, claudin-1, and zonula occludens-1(ZO-1) in colon tissues.High-throughput Meta-amplicon library sequencing was used to detect changes in the intestinal flora of mice.The results indicated that the 6-shogaol group, the berberine group, and the combination group showed significantly relieved intestinal injury, reduced number of F4/80-labeled positive macrophages in colon tissues, increased protein expression of mucin-2, claudin-1, and ZO-1, and decreased serum le-vels of TNF-α, IL-1β, and IL-6.Shannon, Simpson, Chao, and Ace indexes of the intestinal flora of mice in the 6-shogaol group and the combination group significantly increased, and Chao and Ace indexes in the berberine group significantly increased.As revealed by the bioinformatics analysis of intestinal flora sequencing, the relative abundance of Verrucomicrobia at the phylum, class, and order levels decreased significantly in all treatment groups after drug administration, while that of Bacillibacteria gradually increased.In the 6-shogaol group and the combination group, Akkermansia muciniphila completely disappeared, but acid-producing bacillus still existed in large quantities.As concluded, both 6-shogaol and berberine can inhibit intestinal inflammation, reduce the infiltration and activation of macrophages, relieve intestinal damage, reduce intestinal permeability, improve the structure of flora, and promote intestinal microecological balance.The combined application of berberine and 6-shogaol has a significant synergistic effect.
